

CRISPR And CRISPR-Associated Genes Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global CRISPR and CRISPR-associated genes market is expected to experience significant growth due to advancements in gene editing technology and increasing applications in biotechnology and agriculture. The market is projected to reach a size of $7.5 billion by 2026, driven by rising demand for personalized medicine and genetic engineering solutions.
Request Sample Report
◍ Thermo Fisher Scientific
◍ Editas Medicine
◍ Caribou Biosciences
◍ CRISPR therapeutics
◍ Intellia therapeutics, Inc.
◍ Cellectis
◍ Horizon Discovery Plc
◍ Sigma Aldrich
◍ Precision Biosciences
◍ Genscript
◍ Sangamo Biosciences Inc.
◍ Lonza Group Limited
◍ Integrated DNA Technologies
◍ New England Biolabs
◍ Origene Technologies
- The competitive landscape of the CRISPR and CRISPRAssociated Genes market includes key players such as Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR Therapeutics, Intellia Therapeutics, Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, Sangamo Biosciences Inc., Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, and Origene Technologies.
-These companies offer CRISPR-based products and services for various applications in biotechnology, agriculture, healthcare, and research.
- Sales revenue actual figures:
- Thermo Fisher Scientific: $25.54 billion
- CRISPR therapeutics: $77.066 million
- Intellia therapeutics, Inc.: $44.725 million
Request Sample Report
◍ Biotechnology Companies
◍ Pharmaceutical Companies
◍ Academic Institutes
◍ Research and Development Institutes
◍ Genome Editing
◍ Genetic Engineering
◍ GRNA Database/Gene Librar
◍ CRISPR Plasmid
◍ Human Stem Cells
◍ Genetically Modified Organisms/Crops
◍ Cell Line Engineering
Request Sample Report
Request Sample Report
$ X Billion USD